IP Licensing Law BlogThe sfAWIS April Networking Social will be held on Wednesday, April 11, 2007 in San Francisco, CA. The event will be sponsored by Genentech and will take place at The Pub at UCSF, Mission Bay, 1675 Owens St., San Francisco, CA.
The event Invitrogen Distinguished Lecture will be held at 6:30 p.m. on April 11, 2007 at the San Diego Marriott – Del Mar. The speaker will be Zhu Chen, Ph.D, Vice President of the Chinese Academy of Sciences. Dr. Chen has made important discoveries in the molecular foundations of several types of human leukemia and was recently named as one of the coordinators for the Human Genome Project in China. Dr. Chen will speak on “Opportunities and Challenges for Life Science and Biotechnology in China.”
The event IBF’s 18th Annual Venture Capital Investing Conference will be held on Wednesday, June 6, 2007 through Friday, June 8, 2007 at the Four Seasons Hotel , 75 Market Street, San Francisco, CA, 94103.
The event 2007 Dean’s Symposium: Exploring Proteins will be held on Friday, April 6, 2007 from 8 a.m. to 5 p.m. at UCSD Mandel Weiss Theatre. The event will cover the following topics: protein folding and function; protein assemblies and machines; and proteins within cells.
The event 11th Annual Life Science Live – At the Opera will be held Wednesday, April 4, 2007 at 6:15 p.m. at the San Diego Civic Theatre and Golden Hall. The event will provide networking with members of the life sciences community and an evening of opera.
The event French-American Biotech Connection will be held Wednesday, April 4, 2007 from 6 to 9 p.m. at the Salk Institute for Biological Studies. The event will compare two successful approaches to fostering innovation in the life sciences. The speakers will include as follows:
The event Licensing: When, What, Where & How will be held on April 3, 2007 from 7:30-11:30 a.m. at Theatre at Office Pavilion, 6920 Carrol Road, San Diego, CA 92121, and will address turning intellectual property assets into cash.
The event Licensing: When, What, Where & How will be held on April 3, 2007 from 7:30-11:30 a.m. at Theatre at Office Pavilion, 6920 Carrol Road, San Diego, CA 92121, and will address turning intellectual property assets into cash.
On April 3, 2007, BIOCOM will hold a legislative roundtable with Congressman Bob Filner. To RSVP or for more information about this event, please contact Faith Picking at fpicking@biocom.org.
I had the opportunity last night to represent the California Biotech Law Blog at the Bay Area Blawgers Event, where I met many of the Bay Area’s most prominent blawgers. Law Professor Eric Goldman at Santa Clara University organized the event, which was attended by more than forty-five blawgers and members of the media, including yours truly.
It was a great privilege to be in the presence of so many Bay Area blawgers, and to have the opportunity to hear first-hand their thoughts on why they blog, how they dealt with the challenges they have encountered in blogging, and the role we are all playing in developing the law today.
The event was such a success that there are already plans in the works for a second Bay Area Blawgers Event later this year.
While the focus of the California Biotech Law Blog has always been very targeted on the subject of California biotech law, this event gave me occasion to step back and look at this blog as part of a larger community of blawgs. We have some very impressive company.
What thoughts did I take away from this event, which are relevant to you as readers of this Blog?
First, I was struck by the fact that the audience of this Blog is very different from the audience of many of my blawger colleagues. The scope of this Blog crosses over a variety of professions and skillsets, all of which share an interest in the very specialized area of biotech law. This was in sharp contrast with the audience of many of my colleagues’ blawgs.
Second, due to the nature of this Blog, we have not run into some of the challenges that many of my colleagues have encountered. This is in large part because we’ve not yet created the same level of controversy with this Blog. is this good or bad? I am not sure–perhaps it is the nature of our subject matter. Or our audience. Certainly, we in the industry have our opinions on the issues, but it may be that we just do not voice them as strongly in this Blog setting as others do. Perhaps this will change down the road.
Third, the tone this Blog has taken to date has been more educational in nature than pushing a particular perspective or agenda. This was in contrast to some of the other blawgs represented at the event.
My final thoughts on this issue: this Blog is still a young blawg and I know that this event and the greater awareness of the larger blawgging community will impact in some way its development. I thank everyone who participated yesterday for giving me the opportunity to develop a better understanding or this Blog’s role in the greater Bay Area blawg community. I am confident that this will work to the benefit of the California Biotech Law Blog, both in its short-term and long-term development.
Software Law Blog Firm EventsProtected by Security by CleanTalk